Free Trial Information
BioCentury | Apr 18, 2020
Politics, Policy & Law

Collaborating to clobber COVID-19

...be a bit more forward looking and rapid moving than the traditional” processes. Steve Usdin, Washington Editor bioMerieux...
Read More
BioCentury | Mar 27, 2020
Product Development

Pharmas to share assets in COVID-19 consortium led by Narasimhan, Gates

...be found at https://www.biocentury.com/coronavirus . Sandi Wong, Assistant Editor Novartis AG Bill & Melinda Gates Foundation Becton Dickinson and Co. bioMerieux S.A. Boehringer...
Read More
BioCentury | Dec 7, 2018
Tools & Techniques

Filaments line up as MS biomarker

...not disclosing when it expects to get it. The company had licensed the technology to bioMerieux S.A....
...Mentioned Alzheimer’s Association, Chicago, Ill. Banyan Biomarkers Inc., Alachua, Fla. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. bioMerieux S.A....
Read More
BioCentury | Nov 16, 2018
Company News

bioMérieux grows China footprint with majority stake in Hybiome

...Hybiome Biomedical Engineering Co. Ltd., Suzhou, China bioMérieux S.A. (Euronext:BIM), Marcy l'Etoile, France Business: Diagnostics Chris Lieu bioMerieux S.A. Suzhou...
Read More
BioCentury | Nov 12, 2018
Company News

bioMérieux grows China footprint with majority stake in Hybiome

...Friday, when it shed €0.40 to €68.40. On Monday, the company lost €1.30 to €67.10. Chris Lieu bioMerieux S.A. Suzhou...
Read More
BioCentury | Aug 1, 2018
Company News

Management tracks: Hologic, Tricidia

...and head of CMC. Sweeney was VP of corporate development and strategic financing lead at bioMerieux S.A....
Read More
BioCentury | Feb 16, 2018
Clinical News

FDA approves Banyan's brain trauma blood test

...the head is about $1,500. Banyan said it has partnered with Abbott Laboratories (NYSE:ABT) and bioMerieux S.A....
Read More
BioCentury | Dec 16, 2017
Company News

Management tracks: Chugai, bioMérieux

Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) said President and COO Tatsuro Kosaka will become president and CEO. He succeeds CEO Osamu Nagayama, who will remain chairman. Diagnostics company bioMérieux S.A. (Euronext:BIM) said Deputy CEO Alexandre Mérieux...
Read More
BioCentury | Dec 8, 2017
Financial News

Diagnostic company Qvella raises $20M in series B

Molecular diagnostics company Qvella Corp. (Richmond Hill, Ontario) raised $20 million in a series B round led by existing investors RA Capital, Whitecap Venture Partners, Hatteras Venture and Sands Capital. New investor bioMérieux S.A. (Euronext:BIM)...
Read More
BioCentury | Dec 5, 2017
Financial News

Qvella raises $20M in series B

Molecular diagnostics company Qvella Corp. (Richmond Hill, Ontario) raised $20 million in a series B round led by existing investors RA Capital, Whitecap Venture Partners, Hatteras Venture and Sands Capital. New investor bioMérieux S.A. (Euronext:BIM)...
Read More
Items per page:
1 - 10 of 331
BioCentury | Apr 18, 2020
Politics, Policy & Law

Collaborating to clobber COVID-19

...be a bit more forward looking and rapid moving than the traditional” processes. Steve Usdin, Washington Editor bioMerieux...
Read More
BioCentury | Mar 27, 2020
Product Development

Pharmas to share assets in COVID-19 consortium led by Narasimhan, Gates

...be found at https://www.biocentury.com/coronavirus . Sandi Wong, Assistant Editor Novartis AG Bill & Melinda Gates Foundation Becton Dickinson and Co. bioMerieux S.A. Boehringer...
Read More
BioCentury | Dec 7, 2018
Tools & Techniques

Filaments line up as MS biomarker

...not disclosing when it expects to get it. The company had licensed the technology to bioMerieux S.A....
...Mentioned Alzheimer’s Association, Chicago, Ill. Banyan Biomarkers Inc., Alachua, Fla. Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. bioMerieux S.A....
Read More
BioCentury | Nov 16, 2018
Company News

bioMérieux grows China footprint with majority stake in Hybiome

...Hybiome Biomedical Engineering Co. Ltd., Suzhou, China bioMérieux S.A. (Euronext:BIM), Marcy l'Etoile, France Business: Diagnostics Chris Lieu bioMerieux S.A. Suzhou...
Read More
BioCentury | Nov 12, 2018
Company News

bioMérieux grows China footprint with majority stake in Hybiome

...Friday, when it shed €0.40 to €68.40. On Monday, the company lost €1.30 to €67.10. Chris Lieu bioMerieux S.A. Suzhou...
Read More
BioCentury | Aug 1, 2018
Company News

Management tracks: Hologic, Tricidia

...and head of CMC. Sweeney was VP of corporate development and strategic financing lead at bioMerieux S.A....
Read More
BioCentury | Feb 16, 2018
Clinical News

FDA approves Banyan's brain trauma blood test

...the head is about $1,500. Banyan said it has partnered with Abbott Laboratories (NYSE:ABT) and bioMerieux S.A....
Read More
BioCentury | Dec 16, 2017
Company News

Management tracks: Chugai, bioMérieux

Chugai Pharmaceutical Co. Ltd. (Tokyo:4519) said President and COO Tatsuro Kosaka will become president and CEO. He succeeds CEO Osamu Nagayama, who will remain chairman. Diagnostics company bioMérieux S.A. (Euronext:BIM) said Deputy CEO Alexandre Mérieux...
Read More
BioCentury | Dec 8, 2017
Financial News

Diagnostic company Qvella raises $20M in series B

Molecular diagnostics company Qvella Corp. (Richmond Hill, Ontario) raised $20 million in a series B round led by existing investors RA Capital, Whitecap Venture Partners, Hatteras Venture and Sands Capital. New investor bioMérieux S.A. (Euronext:BIM)...
Read More
BioCentury | Dec 5, 2017
Financial News

Qvella raises $20M in series B

Molecular diagnostics company Qvella Corp. (Richmond Hill, Ontario) raised $20 million in a series B round led by existing investors RA Capital, Whitecap Venture Partners, Hatteras Venture and Sands Capital. New investor bioMérieux S.A. (Euronext:BIM)...
Read More
Items per page:
1 - 10 of 331